Validation of the Beck Depression Inventory II in HIV-positive patients

West Indian Med J. 2010 Jul;59(4):374-9.

Abstract

Objective: Research on depression among HIV-positive patients has been limited by the lack of a valid and reliable measure of depression. This project addresses this problem by exploring the internal consistency reliability and the concurrent and discriminant validity of the Beck Depression Inventory-II (BDI-II) using HIV-positive patients in Jamaica.

Method: Patients from three HIV clinics in Jamaica (n = 191 patients; 61% female, 39% male, mean age 40.5-10 years) were administered the BDI-II along with the Centre for Epidemiological Studies -Depression Scale (CES-D) and the Social Provisions Scale.

Results: Overall, the BDI-II was found to have a high degree of reliability (alpha = 0.89). The scale also had good concurrent validity as evidenced by a high correlation with scores on the CES-D (r = 0.74) and acceptable discriminant validity as demonstrated through a moderate correlation with the Social Provisions Scale (r = -0.42). This pattern of scores suggests that the majority of the variance underlying the BDI-II assesses depression (55%) while a smaller degree of the variability (18%) measures a conceptually similar but distinct concept.

Conclusion: The BDI-II is a sufficiently reliable and valid measure for assessing depression in HIV-positive patients.

Publication types

  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Adult
  • Depression / diagnosis*
  • Depression / epidemiology
  • Depression / psychology*
  • Female
  • HIV Seropositivity / psychology*
  • Humans
  • Jamaica / epidemiology
  • Male
  • Psychiatric Status Rating Scales*
  • Reproducibility of Results
  • Risk Factors